Stimmen zu CDISC
CDISC trifft auf breite Unterstützung und Zustimmung in der Branche. Dies belegt eine Auswahl an Kommentaren, die gleichzeitig die Bedeutung wie Notwendigkeit eines Standards unterstreichen:
"Just CDISC it" (Steve Wilson – Biostatistician FDA)
"CDISC is the 'gold' standard for clinical Data Management." (Elaine Job – Aventis Pharmaceuticals)
"CDISC is for me the promise of an easier and more financially efficient way to do business in the world of clinical trials" (Michele Thomas – GlaxoSmithKline)
"CDISC espouses the cause of developing global standards – a challenge we willingly face. This is a logical step after having implemented standards in our local environment." (Dr. Johann Brüning - Schering AG)
"To see a set of standards be developed to this level by representatives of companies that have different ways of doing things is truly remarkable." (Fred Wood – Procter & Gamble Pharmaceuticals)
"With backing by the pharmaceutical industry, CROs and leading technology companies, I believe there is real promise for CDISC to be a magnet for initiatives for clinical drug development data standards. The goal of industry-wide standards in this arena is no longer over the horizon; it is coming into full view. (...) There is al real hunger for industry standards." (Dr. Steve Ruberg - Eli Lilly and Company)
"Pharmaceutical companies have an unprecedented opportunity to reduce time to market by automating their processes. To achieve this, the technology used to create tomorrow's networked clinical applications and submissions must be standardized. CDISC addresses the critical need for industry standards and can dramatically improve the way organizations conduct their drug development process." (Philip Lee - Domain Pharma)
"We see benefits in terms of working with co-development and outsourcing partners. We are, therefore, very committed to the finalization of the CDISC standards." (Hugh Donovan - Aventis)
"By developing global standards for clinical trial data, CDISC will improve the efficiency and quality of clinical research, and enhance the development of new drugs to improve the lives of patients." (Per Peterson - Johnson & Johnson)
"These standards will have a significant positive impact on the development of clinical software products and will enable companies to adopt new technologies more quickly and easily. We have already seen great excitement from our clients in deploying the CDISC standards." (Sam Hume - CB Technologies)
"Internationally recognized standards for data interchange are vital to fully realizing the Internet's extraordinary potential to accelerate clinical research." (Anne Wiles - Quintiles E-Business)
